[CIS PIDD] [cis-pidd] VS: IVIG or SCIG

[CIS-PIDD]

Is there a contraindication for anti platelet therapy?

> On Jun 7, 2017, at 08:32, CIS-PIDD <cis-pidd at lists.clinimmsoc.org> wrote:
> 
> Out of I think 3 such CVID patients I have seen, 1 had recurrent thrombosis, but that was before present day preparations and she had multiple (!) other risk factors.
>  
> If she refuses SCIG (which I would prefer) would then use IVIG.
>  
> Mikko
>  
>  
>  
> Mikko Seppänen
> Director, Adjunct Professor, MD, PhD
> Hospital District of Helsinki and Uusimaa, Children’s Hospital, Rare Disease Center
> P.O.Box 280, 00029 HUS |Lastenlinnantie 2, Helsinki
> Senior Consultant
> Hospital District of Helsinki and Uusimaa, Inflammation Center, Adult Primary Immunodeficiency Outpatient Clinic 
> mikko.seppanen at hus.fi
> +358 9 47180201<image001.gif>| +358 50 4279606
> faxi +358 9 47174703
> www.hus.fi; www.harvinaissairaudet.fi 
>  
>  <image002.jpg>
>   
>  
>  
>  
> Lähettäjä: cis-pidd at lyris.dundee.net [mailto:cis-pidd at lyris.dundee.net] Puolesta CIS-PIDD
> Lähetetty: 6. kesäkuuta 2017 18:53
> Vastaanottaja: CIS-PIDD <cis-pidd at lyris.dundee.net>
> Aihe: [cis-pidd] IVIG or SCIG
>  
> Colleagues:
>  
> I consulted on a 46yo F who requires immunoglobulin replacement therapy.  She is s/p bilateral mastectomy for breast cancer and on tamoxifen as maintenance. 
>  
> Tamoxifen “slightly” increases the risk for DVTs etc.
>  
> However, the patient would prefer IVIG over SCIG.
>  
> Does anyone have experience with the combination of IVIG + tamoxifen and the risk of thrombotic events?
>  
> Thank you for your help.
>  
> Joe Church
> Children’s Hospital Los Angeles
>  
>  
>  
> . 
> CONFIDENTIALITY NOTICE: This e-mail message, including any attachments, 
> is for the sole use of the intended recipient(s) and may contain confidential
> or legally privileged information. Any unauthorized review, use, disclosure
> or distribution is prohibited. If you are not the intended recipient, please
> contact the sender by reply e-mail and destroy all copies of this original message.
> 
> ---
> 
> You are currently subscribed to cis-pidd as: mikko.seppanen at hus.fi.
> 
> To unsubscribe click here: http://cts.dundee.net/u?id=99266512.00d254228cd4b291924022bf56fac1f0&n=T&l=cis-pidd&o=4415146
> 
> (It may be necessary to cut and paste the above URL if the line is broken)
> 
> or send a blank email to leave-4415146-99266512.00d254228cd4b291924022bf56fac1f0 at lyris.dundee.net
> 
> ---
> 
> You are currently subscribed to cis-pidd as: shidave at gmail.com.
> 
> To unsubscribe click here: http://cts.dundee.net/u?id=104312920.b95357c06f6e1b971ba6b89dfa47ac0d&n=T&l=cis-pidd&o=4416176
> 
> (It may be necessary to cut and paste the above URL if the line is broken)
> 
> or send a blank email to leave-4416176-104312920.b95357c06f6e1b971ba6b89dfa47ac0d at lyris.dundee.net

---
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://cts.dundee.net/u?id=96396833.5a9591ccd1e327fe6bc4d1543298c482&n=T&l=cis-pidd&o=4416193
or send a blank email to leave-4416193-96396833.5a9591ccd1e327fe6bc4d1543298c482 at lyris.dundee.net
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://pairlist7.pair.net/pipermail/pagid/attachments/20170607/4ba5a19b/attachment-0001.html>